Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125479553 | 12547955 | 3 | F | 200309 | 20160802 | 20160712 | 20160812 | EXP | FR-AMGEN-FRASP2016089270 | AMGEN | 55.00 | YR | A | F | Y | 0.00000 | 20160812 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125479553 | 12547955 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | N | 103795 | UNKNOWN FORMULATION | ||||||||
| 125479553 | 12547955 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | N | 103795 | UNKNOWN FORMULATION | ||||||||
| 125479553 | 12547955 | 3 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | N | 103795 | UNKNOWN FORMULATION | ||||||||
| 125479553 | 12547955 | 4 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | N | 103795 | UNKNOWN FORMULATION | ||||||||
| 125479553 | 12547955 | 5 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | N | 103795 | UNKNOWN FORMULATION | ||||||||
| 125479553 | 12547955 | 6 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | N | 103795 | UNKNOWN FORMULATION | ||||||||
| 125479553 | 12547955 | 7 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | N | 103795 | UNKNOWN FORMULATION | ||||||||
| 125479553 | 12547955 | 8 | SS | CELEBREX | CELECOXIB | 1 | Unknown | UNK | 0 | ||||||||||
| 125479553 | 12547955 | 9 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 125479553 | 12547955 | 10 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 125479553 | 12547955 | 11 | SS | VIOXX | ROFECOXIB | 1 | Unknown | UNK | 0 | ||||||||||
| 125479553 | 12547955 | 12 | SS | ACUPAN | NEFOPAM HYDROCHLORIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125479553 | 12547955 | 1 | Rheumatoid arthritis |
| 125479553 | 12547955 | 8 | Rheumatoid arthritis |
| 125479553 | 12547955 | 9 | Rheumatoid arthritis |
| 125479553 | 12547955 | 10 | Rheumatoid arthritis |
| 125479553 | 12547955 | 11 | Rheumatoid arthritis |
| 125479553 | 12547955 | 12 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125479553 | 12547955 | OT |
| 125479553 | 12547955 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125479553 | 12547955 | Anxiety | |
| 125479553 | 12547955 | Arthralgia | |
| 125479553 | 12547955 | Balance disorder | |
| 125479553 | 12547955 | Depression | |
| 125479553 | 12547955 | Diarrhoea | |
| 125479553 | 12547955 | Encopresis | |
| 125479553 | 12547955 | Gastrointestinal inflammation | |
| 125479553 | 12547955 | Infection susceptibility increased | |
| 125479553 | 12547955 | Musculoskeletal stiffness | |
| 125479553 | 12547955 | Pain | |
| 125479553 | 12547955 | Skin irritation | |
| 125479553 | 12547955 | Staphylococcal infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125479553 | 12547955 | 1 | 200102 | 0 | ||
| 125479553 | 12547955 | 2 | 20031108 | 20040308 | 0 | |
| 125479553 | 12547955 | 3 | 20040317 | 0 | ||
| 125479553 | 12547955 | 4 | 20040707 | 0 | ||
| 125479553 | 12547955 | 5 | 2004 | 0 | ||
| 125479553 | 12547955 | 6 | 2004 | 0 |